The largest database of trusted experimental protocols

6 protocols using ccg 1423

1

Spheroid Migration Assay in 3D Collagen

Check if the same lab product or an alternative is used in the 5 most similar protocols
U87-NT cells were seeded at 3 × 103/well in low adherence 96 well plates (ThermoFisher, Altrincham, UK) as previously described [14 (link)]. Three days after seeding, spheroids contained within the wells were embedded in rat tail collagen V (Corning Life Science, Glendale, AZ 85301, USA), polymerisation was achieved with 1 M NaOH. The inhibitors CCG-1423 and Rhosin-HCl (Tocris, Bristol, UK) were resuspended in DMSO and added at a predetermined anti-migratory concentration (CCG-1423: 500 nM, Rhosin: 1 µM). Control spheroids were mock-treated with DMSO-supplemented medium only. Spheroids were allowed to grow for 72 h in collagen, fixed with 4% PFA and labelled with Phalloidin-TRITC (ThermoFisher, Altrincham, UK) in their collagen plugs. Image z-stacks of spheroids were acquired on a Zeiss 880 LSM confocal microscope (Zeiss, Birmingham, UK) with an EC plan-neofluar 10× objective. For analysis maximum projections of the z-stacks were used. The resulting grey-scale images were inverted and using the free-hand selection tool in ImageJ, the outline of the spheroid as well as of the gaps between migration cells were drawn and the area measured (for illustration see Supplement Figure S2).
+ Open protocol
+ Expand
2

Skin Explant Culture to Assess CCG-1423 Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6J mice were sacrificed at p26, backs shaved, skin removed, and then 6-mm punch (Integra; 33-36) was used to generate circular punches, which were subsequently attached to the bottom of 6-well TC plates (Corning; 3516) with 6uL of Matrigel (Corning; 356237). Explants were cultured in 154CF media (Gibco; M15CF500) supplemented with 15% chelated FBS (GE HyClone; SH30396.03), 1% Penicillin Streptomycin (Gibco; 15140-122), 0.05 mM CaCl2 (Gibco; 50-9702), 0.4% Amphotericin B (Gibco; 15290026), 0.01% Plasmocin (Invitrogen; NC9886956), and 1% HKGS (Gibco; S-0001-5). Paired explants from same mouse were either treated with 150 μm CCG-1423 (Tocris; 5277) or DMSO control. Explants were cultured for 72 h, then fixed in 4% PFA for 24 h and imbedded in paraffin blocks for H&E and immunofluorescence staining.
+ Open protocol
+ Expand
3

Inhibitor Effects on Cell Spreading

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inhibitor experiments were performed in serum-containing medium, and treatments began 5 minutes prior to plating (spreading) or 5 minutes prior to scratch-wounding. Small-molecule inhibitors against signaling proteins, CDC42 (ZCL 278, 55 μM in DMSO), ERK (FR 180204, 3 μM in DMSO), FAK (PF 573228, 40 nM in DMSO), PI3K (LY294002, 5 μM in DMSO), RAC (EHT 1864, 600 nM in DMSO), and RHOA (CCG 1423, 3 μM in DMSO) were obtained from Tocris Bioscience, Bristol, UK. In order to ensure specificity of the inhibitors, dose-range studies were conducted with 3 doses for each inhibitor. Concentrations were chosen based on the lowest concentration for significant effect on spreading on any matrix. All inhibitors were used at a concentration less than 5x of the reported In vitro ID50 for each molecule.
+ Open protocol
+ Expand
4

Modulation of MRTF-A/B and Actin Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
In Figure 2H, human coronary artery SMCs were transduced with MRTF-A virus or MRTF-B virus (200 MOI) in 1% Smooth Muscle Differentiation Supplement (SMDS, Life Technologies, S-008-5) M231 medium for 96h. Subsequently, the medium was exchanged for fresh 1% SMDS medium, and 10μM CCG-1423 (Tocris Bioscience, #5233) or the corresponding volume of DMSO (Sigma-Aldrich, #D5879) added directly the medium. Cells were then harvested after an additional 72h.
To depolymerize actin in human coronary artery endothelial cells, Latrunculin B (Lat B, 100nM, Calbiochem, #428020) or DMSO (Sigma-Aldrich, #D5879) was added at 96h after transducing with MRTF-B virus, and cells were harvested after additional 24h. Before adding the LatB, cells were also transferred to low-serum medium (2.5% FBS) for a 24h period.
To inhibit the YAP-TEAD interaction, 2μM verteporfin (Sigma-Aldrich, SML0534-5MG) or the corresponding volume of DMSO (Sigma-Aldrich, #D5879) was added to the medium after transduction with MRTF-B virus for 72h (human coronary artery SMCs). Cells were harvested for RNA extraction after an additional 24h.
+ Open protocol
+ Expand
5

Inhibitor Compounds for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tolcapone (S4021), etretinate (S4699), KU-60019 (S1570), tomatidine (S9430), and citalopram HBr (S4749) were obtained from Selleckchem. Z-VEID-FMK (ab142025) was obtained from Abcam. CCG-1423 (5233) was obtained from Tocris. SCH-23390 hydrochloride (HY-19545A) was obtained from MedChemExpress. N-Butylidenephthalide, (E) + (Z) (sc-279727) was obtained from Santa Cruz Biotechnology. Prior to use, all inhibitors were resuspended in dimethyl sulfoxide (DMSO), with the exception of n-Butylidenephthalide which was resuspended in ethanol.
+ Open protocol
+ Expand
6

3D Glioma Spheroid Migration Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The glioma cell lines U251 and U87 were grown in vitro as previously described [11] (link). Spheroids were generated from the cells in low adherent 96-well plates (Nunc, UK) as previously described [12] (link), embedded in collagen and treated with a panel of small molecule inhibitors at predetermined anti-migratory concentrations, including 6-bromoindirubin-3-oxime (5 µM) (BIO, Selleckchem), latrunculin A (10 µM) (lat A, Tocris) and CCG-1423 (500 nM) (Tocris). Glioma cells emanating away from the original spheroid cores were allowed to migrate into collagen for 72 h. After completion of the experiment, the whole collagen plugs containing spheroids and migrating cells were fixed with PFA (4% in PBS, overnight at 4°C).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!